Hims & Hers: Ready To Outperform Further
Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
A shake-up may be brewing in the market for GLP-1 diet drugs Friday, and it's making itself felt all across the field of ...
Hims & Hers Health: The Market Is Likely Wrong
Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...
Is Hims & Hers Stock in Trouble?
Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...
bovnews19h
HIMS’s Recent Drop: What’s Causing the Decline?
In recent trading, Hims & Hers Health Inc (HIMS) stock price has shown some volatility, fluctuating 9.60% over the last five trades and -10.88% over the past 30 trades. This represents a notable shift ...
Short Report: Hims and Hers bearish levels at record highs
Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest trends among some of the most ...
Cautious Outlook on Hims & Hers Health Amid Regulatory Risks and Revenue Concerns
In a report released today, Allen Lutz from Bank of America Securities reiterated a Sell rating on Hims & Hers Health (HIMS – Research ...
Hims & Hers in focus as Eli Lilly obesity drug sales disappoint
Eli Lilly (NYSE:LLY) shares sold off on Tuesday after the Indiana-based pharma giant's Q4 and 2024 preliminary sales results ...